B. Braun Medical – Recall of ceftazidime injection
April 25, 2019 - B. Braun Medical announced a voluntary user-level recall of one lot of ceftazidime injection because the recalled lot contained elevated high molecular weight polymers (HMWPs). Additional tests for the recalled lot also indicated levels that were out of trend when compared with prior stability data.
Top